Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
05/1998
05/14/1998WO1998020007A1 Quinolines and their therapeutic use
05/14/1998WO1998019706A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998WO1998019699A1 Use of growth hormone or a growth hormone secretagogue for promoting bone formation
05/14/1998WO1998019697A2 Novel pharmaceutical compositions
05/14/1998WO1998019649A2 Methods and compositions for inhibition of angiogenesis
05/14/1998WO1998007859A3 Secreted proteins and polynucleotides encoding them
05/14/1998CA2270927A1 Novel pharmaceutical compositions
05/14/1998CA2270922A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
05/14/1998CA2269858A1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
05/14/1998CA2268126A1 Quinolines and their therapeutic use
05/13/1998EP0840801A2 Methods and compositions for identifying morphogen analogs
05/13/1998EP0840738A1 Colchicine derivatives, the use thereof and formulations containing them
05/13/1998EP0840608A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
05/12/1998US5750688 Reacting an halogenated amine with an oxybenzoic ester; then a 2-(oxyphenyl-)benzothiophene compound
05/12/1998US5750576 Triphenylethylenes for the prevention and treatment of osteoporosis
05/12/1998US5750543 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
05/12/1998US5750387 DNA encoing leucyl TRNA synthetase from staphylococcus aureus
05/07/1998WO1998018925A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998WO1998018812A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998WO1998018810A1 Immunostimulatory nucleic acid molecules
05/07/1998WO1998018785A1 Substituted oximes derivatives useful as neurokinin antagonists
05/07/1998WO1998018782A1 2-pyrimidineamine derivatives and processes for their preparation
05/07/1998WO1998018779A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018778A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018777A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018776A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018775A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018774A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018773A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018772A1 NOVEL cis-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
05/07/1998WO1998018771A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998WO1998018759A1 Vitamin d analogues
05/07/1998WO1998018480A1 Vascular endothelial growth factor (vegf) nucleic acid ligand complexes
05/07/1998WO1998018464A1 Substituted tricyclics
05/07/1998WO1998018461A1 Integrin antagonists
05/07/1998WO1998018460A1 Integrin antagonists
05/07/1998WO1998009985A3 Anti-inflammatory peptides and uses thereof
05/07/1998WO1998008517A3 Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
05/07/1998CA2270345A1 Immunostimulatory nucleic acid molecules
05/07/1998CA2270113A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270111A1 Novel (-)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270057A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270056A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2270055A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269974A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269973A1 Novel cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269970A1 Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269936A1 Novel trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
05/07/1998CA2269722A1 Oligomers which inhibit the expression of interleukin genes
05/07/1998CA2269642A1 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
05/07/1998CA2269203A1 Substituted tricyclics
05/07/1998CA2269095A1 2-pyrimidineamine derivatives and processes for their preparation
05/07/1998CA2268940A1 Integrin antagonists
05/06/1998EP0839806A1 Substituted tricyclics
05/06/1998EP0730577B1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds
05/06/1998EP0705254B1 Phenyl heterocycles as cyclooxygenase-2 inhibitors
05/06/1998CN1181075A Substituted isoxazoles for the treatment of inflammation
05/06/1998CN1181012A Method of lessening the rish of non-vertebral bone fractures
05/06/1998CN1181008A Method of lessening the risk of vertebral fractures
05/06/1998CN1180531A Chinese drugs soft extract used to activate blood flow and its preparation method
05/06/1998CN1180530A Chinese drugs preparation for strengthening bone and its production method
05/05/1998US5747510 Pharmaceutical unit dosage formulations
05/05/1998US5747319 Human mRNA editing enzyme
05/05/1998US5747034 Methods and materials for the induction of T cell anergy
04/1998
04/30/1998WO1998017791A1 Production of cartilage tissue using cells isolated from wharton's jelly
04/30/1998WO1998017655A1 Metalloproteinase inhibitors
04/30/1998WO1998017645A1 α-AMINO SULFONYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE INHIBITORS
04/30/1998WO1998017643A1 Heteroaryl succinamides and their use as metalloproteinase inhibitors
04/30/1998WO1998017267A1 Compositions and methods for treating bone deficit conditions
04/30/1998WO1998004694A3 Secreted proteins and polynucleotides encoding them
04/30/1998CA2269283A1 Metalloproteinase inhibitors
04/30/1998CA2269121A1 Production of cartilage tissue using cells isolated from wharton's jelly
04/30/1998CA2268418A1 .alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors
04/29/1998EP0838464A1 Substituted benzo(b)thiophene compounds having activity as selective estrogen receptor modulators
04/29/1998EP0838462A1 Benzothiophene compounds, intermediates, compositions, and methods
04/29/1998EP0838461A2 Substituted 2,3-aryl-benzothiophene compounds having estrogenic activity
04/29/1998EP0838459A1 Naphthyl compounds, compositions, and methods
04/29/1998EP0837932A1 Macrophage activating factors derived from cloned vitamin d binding protein
04/29/1998EP0837860A1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO 3,4-c]-1,2,4-TRIAZOLO 4,3-$g(a)]PYRIDINES
04/29/1998EP0837693A1 Method of treating rheumatoid arthritis with low dose type ii collagen
04/29/1998EP0837690A1 A stabilized pharmaceutical formulation comprising a growth hormone and a peptide comprising at least one basic amino acid residue and at least one acid amino acid residue
04/29/1998EP0837678A1 N,n-dimethyl-8,8-dipropyl-2-azaspiro 4,5]decane-2-propanamine dimaleate
04/29/1998CN1180358A Bridged indoles as matrix metalloprotease inhibitors
04/29/1998CN1180352A Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
04/29/1998CN1179978A Drug composition for curing osteoporosis
04/29/1998CN1179975A Drug composition for curing osteoporosis
04/29/1998CN1179958A Chinese patent drug
04/29/1998CN1179957A Spur medicinal powder and preparing method thereof
04/29/1998CN1179956A Specific drug for curing rheumatic arthritis and rheumatoid arthritis
04/29/1998CN1179944A Use of strontium salts for production of pharmaceutical compositions intended for treatment of arthrosis
04/25/1998CA2218756A1 Substituted benzo¢b!thiophene compounds having activity as selective estrogen receptor modulators
04/24/1998CA2215647A1 Naphthyl compounds, compositions, and methods
04/23/1998WO1998016644A1 Fibroblast growth factor homologs
04/23/1998WO1998016520A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016506A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016505A1 SULFONAMIDE INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
04/23/1998WO1998016504A2 SULFONAMIDE SUBSTITUTED ASPARTIC ACID INTERLEUKIN-1β CONVERTING ENZYME INHIBITORS
04/23/1998WO1998016503A2 The preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
04/23/1998WO1998016184A2 Purine l-nucleosides, analogs and uses thereof
04/23/1998WO1998008546A3 Therapeutic combinations of rar antagonists and rxr agonists and use thereof
1 ... 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 ... 820